Elena A. Grishina

2/1 Barrikadnaya Street
Moscow, MOW 123995, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Dual inhibition of VEGF-A and angiopoietin-2 in the treatment of neovascular age-related macular degeneration and diabetic macular edema

Dual inhibition of VEGF-A and angiopoietin-2 in the treatment of neovascular age-related macular degeneration and diabetic macular edema

Journal: Vestnik oftalmologii

Published: December 28, 2024

The place of ciclosporin A cationic emulsion 0.1% in the therapy of xerophthalmia

The place of ciclosporin A cationic emulsion 0.1% in the therapy of xerophthalmia

Journal: Vestnik oftalmologii

Published: May 14, 2024

Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.

Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.

Journal: Pharmacogenetics and genomics

Published: October 18, 2022

Evaluation of the association of polymorphisms of the CYP2C8 gene with the efficacy and safety of ketorolac in patients with postoperative pain syndrome

Evaluation of the association of polymorphisms of the CYP2C8 gene with the efficacy and safety of ketorolac in patients with postoperative pain syndrome

Journal: Terapevticheskii arkhiv

Published: June 16, 2022

CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study.

CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study.

Journal: Drug metabolism and personalized therapy

Published: May 30, 2022

Effect of CYP2D64, CYP2D610 polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma.

Effect of CYP2D64, CYP2D610 polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma.

Journal: Drug metabolism and personalized therapy

Published: March 08, 2022

CYP2C8, PTGS-1, 2 gene polymorphisms prevalence associated with sensitivity to non-steroidal anti-inflammatory drugs among North Caucasus ethnic groups

CYP2C8, PTGS-1, 2 gene polymorphisms prevalence associated with sensitivity to non-steroidal anti-inflammatory drugs among North Caucasus ethnic groups

Journal: Terapevticheskii arkhiv

Published: January 27, 2022

Effects of CYP2C19*17 genetic polymorphisms on plasma and saliva concentrations of diazepam in patients with alcohol withdrawal syndrome.

Effects of CYP2C19*17 genetic polymorphisms on plasma and saliva concentrations of diazepam in patients with alcohol withdrawal syndrome.

Journal: Psychiatric genetics

Published: January 10, 2022

Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder.

Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder.

Journal: Psychopharmacology bulletin

Published: December 10, 2021

Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome.

Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome.

Journal: Hospital pharmacy

Published: November 01, 2021

Impact of CYP2D6 Polymorphism on Equilibrium Concentration of Fluoxetine in Patients Diagnosed With Major Depressive Disorder and Comorbid Alcohol Use Disorders.

Impact of CYP2D6 Polymorphism on Equilibrium Concentration of Fluoxetine in Patients Diagnosed With Major Depressive Disorder and Comorbid Alcohol Use Disorders.

Journal: Journal of psychiatric practice

Published: September 16, 2021

MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction.

MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction.

Journal: Pharmacogenomics and personalized medicine

Published: June 16, 2021

Showing 1-12 of 55

Last Updated: 09/26/2026